logo
Select company
Select metric
$ -43.7MConsolidated Income
VS
Market
21
Sector
41
Industry
53
History
18
$ 1.3Close
$ 1.09 - $ 16.95 52-Week Range
Ticker Information

Ticker

ERNA

Company Name

ERNEXA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ERNEXA THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ERNA - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -43.7M
3/31/2025$ -46.09M
12/31/2024$ -44.54M
9/30/2024$ -44.93M
6/30/2024$ -23.92M
3/31/2024$ -22.9M
12/31/2023$ -21.67M
9/30/2023$ -20M
6/30/2023$ -21.73M
3/31/2023$ -20.62M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ERNEXA THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -6.01M.
  • Over the past 5 years, ERNEXA THERAPEUTICS INC's average Cons. Inc. has been $ -44.07M.
  • The median Cons. Inc. for ERNEXA THERAPEUTICS INC during this period was $ -26.69M
  • ERNEXA THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -4.42M.
  • The lowest Cons. Inc. recorded by ERNEXA THERAPEUTICS INC in the same timeframe $ -122.31M

ERNEXA THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
BRTX : BIORESTORATIVE THERAPIES INC $ -10.72MVYNE : VYNE THERAPEUTICS INC $ -38.55MIBIO : IBIO INC $ -18.38MLEXX : LEXARIA BIOSCIENCE CORP $ -11.4MLYRA : LYRA THERAPEUTICS INC $ -38.84MPULM : PULMATRIX INC $ -7.93MAPRE : APREA THERAPEUTICS INC $ -13.85MHCWB : HCW BIOLOGICS INC $ -11.4MMGRX : MANGOCEUTICALS INC $ -14.2MPHIO : PHIO PHARMACEUTICALS CORP $ -7.08M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

ERNA - Consolidated Income, Last 5 years

$ -122.31M

Minimum

Dec 31, 2021

$ -4.42M

Maximum

Dec 31, 2020

$ -44.07M

Average

$ -26.69M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.09M with a standard deviation of $ 116.52M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.09M
median$ -2.07M
std$ 116.52M